Cargando…

Correction: Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia

Detalles Bibliográficos
Autores principales:	Harding-Esch, Emma M., Sillah, Ansumana, Edwards, Tansy, Burr, Sarah E., Hart, John D., Joof, Hassan, Laye, Mass, Makalo, Pateh, Manjang, Ahmed, Molina, Sandra, Sarr-Sissoho, Isatou, Quinn, Thomas C., Lietman, Tom, Holland, Martin J., Mabey, David, West, Sheila K., Bailey, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683098/ http://dx.doi.org/10.1371/annotation/0bae8b34-5ae7-4044-a071-8d88d520a01b

Ejemplares similares

Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study
por: Harding-Esch, Emma, et al.
Publicado: (2015)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2019)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities
por: Burton, Matthew J., et al.
Publicado: (2010)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020?
por: Harding-Esch, Emma M., et al.
Publicado: (2009)

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)

Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia
por: Migchelsen, Stephanie J., et al.
Publicado: (2017)

Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2017)

Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial
por: Harding-Esch, Emma M., et al.
Publicado: (2010)

Diagnostic Accuracy of a Prototype Point-of-Care Test for Ocular Chlamydia trachomatis under Field Conditions in The Gambia and Senegal
por: Harding-Esch, Emma M., et al.
Publicado: (2011)

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx
por: Gladstone, Rebecca A., et al.
Publicado: (2021)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?
por: Burr, Sarah E., et al.
Publicado: (2016)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control
por: Bojang, Ebrima, et al.
Publicado: (2017)

A systems serology approach to the investigation of infection-induced antibody responses and protection in trachoma
por: Barton, Amber, et al.
Publicado: (2023)

An outbreak of acute haemorrhagic conjunctivitis associated with coxsackievirus A24 variant in The Gambia, West Africa
por: Burr, Sarah E., et al.
Publicado: (2017)

Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma
por: Pickering, Harry, et al.
Publicado: (2019)

Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies
por: Migchelsen, Stephanie J., et al.
Publicado: (2017)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
por: Amza, Abdou, et al.
Publicado: (2021)

Longitudinal changes in tear cytokines and antimicrobial proteins in trachomatous disease
por: Barton, Amber, et al.
Publicado: (2023)

Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study
por: Roberts, Chrissy h., et al.
Publicado: (2015)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

The Gambia has eliminated trachoma as a public health problem: Challenges and successes
por: Aboe, Agatha, et al.
Publicado: (2022)

Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
por: Hong, Kevin Cyrus, et al.
Publicado: (2009)

Stopping azithromycin mass drug administration for trachoma: A systematic review
por: Mahmud, Hamidah, et al.
Publicado: (2021)

Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
por: Godwin, William, et al.
Publicado: (2020)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws
por: Marks, Michael, et al.
Publicado: (2015)

Patients’ Perceptions of Trichiasis Surgery: Results from the Partnership for Rapid Elimination of Trachoma (PRET) Surgery Clinical Trial
por: Oktavec, Kathleen C., et al.
Publicado: (2014)

Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands
por: Marks, M, et al.
Publicado: (2016)

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data
por: Goncalves, Adriana, et al.
Publicado: (2016)

Profiling and validation of individual and patterns of Chlamydia trachomatis-specific antibody responses in trachomatous trichiasis
por: Pickering, Harry, et al.
Publicado: (2017)

Conjunctival MicroRNA Expression in Inflammatory Trachomatous Scarring
por: Derrick, Tamsyn, et al.
Publicado: (2013)

The conjunctival microbiome in health and trachomatous disease: a case control study
por: Zhou, Yanjiao, et al.
Publicado: (2014)

Prevalence of Active and Latent Yaws in the Solomon Islands 18 Months after Azithromycin Mass Drug Administration for Trachoma
por: Marks, Michael, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0rdrdkvtd24i64d26g60hci7k8